ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 122 filers reported holding ANIKA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,005 | -43.1% | 14,332 | -20.7% | 0.00% | – |
| Q2 2023 | $469,510 | +9.7% | 18,072 | +21.0% | 0.00% | – |
| Q1 2023 | $428,000 | +128043.7% | 14,936 | +32.6% | 0.00% | – |
| Q4 2022 | $334 | -99.9% | 11,264 | +6.2% | 0.00% | – |
| Q3 2022 | $253,000 | +16.1% | 10,606 | +8.8% | 0.00% | – |
| Q2 2022 | $218,000 | +1.4% | 9,750 | +14.0% | 0.00% | – |
| Q1 2022 | $215,000 | -38.6% | 8,552 | -12.5% | 0.00% | – |
| Q4 2021 | $350,000 | +24.1% | 9,778 | +47.3% | 0.00% | – |
| Q3 2021 | $282,000 | -2.4% | 6,636 | -0.5% | 0.00% | – |
| Q2 2021 | $289,000 | +11.6% | 6,666 | +5.4% | 0.00% | – |
| Q1 2021 | $259,000 | -36.0% | 6,327 | -29.3% | 0.00% | – |
| Q4 2020 | $405,000 | +48.9% | 8,955 | +12.7% | 0.00% | – |
| Q3 2020 | $272,000 | -1.8% | 7,943 | +8.1% | 0.00% | – |
| Q2 2020 | $277,000 | +33.8% | 7,347 | +2.1% | 0.00% | – |
| Q1 2020 | $207,000 | -45.5% | 7,194 | -2.1% | 0.00% | – |
| Q4 2019 | $380,000 | +5.0% | 7,347 | +11.3% | 0.00% | – |
| Q3 2019 | $362,000 | +38.7% | 6,599 | -0.0% | 0.00% | – |
| Q2 2019 | $261,000 | -63.9% | 6,601 | -72.4% | 0.00% | – |
| Q1 2019 | $723,000 | +2.6% | 23,925 | +14.0% | 0.00% | – |
| Q4 2018 | $705,000 | -73.7% | 20,989 | -67.0% | 0.00% | -100.0% |
| Q3 2018 | $2,680,000 | +840.4% | 63,529 | +613.6% | 0.00% | – |
| Q2 2018 | $285,000 | -73.6% | 8,903 | -59.0% | 0.00% | – |
| Q1 2018 | $1,080,000 | -35.9% | 21,723 | -30.5% | 0.00% | – |
| Q4 2017 | $1,685,000 | +71.6% | 31,254 | +85.4% | 0.00% | – |
| Q3 2017 | $982,000 | +3286.2% | 16,859 | +2781.9% | 0.00% | – |
| Q2 2017 | $29,000 | -98.1% | 585 | -98.3% | 0.00% | – |
| Q1 2017 | $1,499,000 | -43.6% | 34,498 | -36.5% | 0.00% | -100.0% |
| Q4 2016 | $2,660,000 | +382.8% | 54,327 | +372.0% | 0.00% | – |
| Q3 2016 | $551,000 | +1152.3% | 11,510 | +1286.7% | 0.00% | – |
| Q2 2016 | $44,000 | +340.0% | 830 | +264.0% | 0.00% | – |
| Q1 2016 | $10,000 | +11.1% | 228 | 0.0% | 0.00% | – |
| Q4 2015 | $9,000 | -98.4% | 228 | -98.5% | 0.00% | – |
| Q4 2013 | $566,000 | – | 14,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |